Table 1.
Demographic and metabolic characteristics of GDM patients at baseline.
| CGM (N=62) |
SMBG (N=62) |
p | |
|---|---|---|---|
| Age (years) | 31.81 ± 4.33 | 31.77 ± 3.77 | 0.965 |
| DM family history | 14 (22.6) | 13 (21.7) | 0.903 |
| Pre-BMI (kg/m2) | 22.23 ± 3.57 | 23.05 ± 3.53 | 0.202 |
| Chronic hypertension before pregnancy | 1 (1.6) | 0 (0) | 0.315 |
| Polycystic ovary syndrome | 4 (6.5) | 7 (11.3) | 0.343 |
| FPG (mmol/L) | 4.97 ± 0.52 | 4.92 ± 0.56 | 0.567 |
| 1hPG (mmol/L) | 10.02 ± 1.66 | 10.15 ± 1.35 | 0.638 |
| 2hPG (mmol/L) | 8.47 ± 1.66 | 8.61 ± 1.32 | 0.615 |
| FINS (pmol/L) | 50.30 (39.90-73.15) | 57.10 (44.7-84.70) | 0.036 |
| 1hINS (pmol/L) | 330.35 (251.65-473.95) | 447.00 (268.80-668.30) | 0.018 |
| 2hINS (pmol/L) | 359.45 (218.05-507.35) | 434.60 (241.10-691.80) | 0.059 |
| HOMA-β | 227.20 (126.95-390.62) | 245.35 (121.94-350.15) | 0.508 |
| HOMA-IR | 1.56 (1.19-2.44) | 1.92 (1.27-2.71) | 0.113 |
| HbA1c (%) | 4.94 ± 0.34 | 5.01 ± 0.36 | 0.248 |
| GA (%) | 13.31 ± 1.65 | 13.15 ± 1.76 | 0.620 |
| HbA1c <6% | 62 (100) | 62 (100) | 1.000 |
| TC (mmol/L) | 5.77 ± 1.00 | 5.77 ± 0.97 | 0.983 |
| TG (mmol/L) | 2.41 ± 0.95 | 2.79 ± 1.28 | 0.062 |
| HDL-C (mmol/L) | 1.87 ± 0.38 | 1.89 ± 0.47 | 0.722 |
| LDL-C (mmol/L) | 2.93 ± 0.91 | 2.82 ± 0.81 | 0.446 |
Data are expressed as mean ± SD or median (interquartile range) or n (%). pre-BMI, body mass index before pregnancy; FPG, fasting plasma glucose; 1hPG, 1-h plasma glucose; 2hPG, 2-h plasma glucose; FINS, fasting insulin; 1hINS, 1-h insulin; 2hINS, 2-h insulin; HbA1c, hemoglobin A1c; GA, glycated albumin; HOMA-IR, homeostasis model assessment for insulin resistance index; HOMA-β, homeostasis model assessment for β-cell function, TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol.